Specialty code 390200000X · New York, NY
NPI
1285925222
Since 2011
Specialty
Specialty code 390200000X
Code 390200000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
161 Fort Washington Ave, 12th Floor
New York, NY, 10032
Phone (212) 305-5293
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$280K
608 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Mary L Bui prescribed most often to Medicare patients was Fluorouracil, with 75 prescriptions and refills. In total Mary L Bui wrote 608 Medicare prescriptions that cost $280K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-15.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Fluorouracil Generic | 75 | 75 | 69 | $2,906 |
| Clobetasol Propionate Generic | 58 | 61 | 35 | $2,155 |
| Calcipotriene Generic | 55 | 67 | 47 | $8,917 |
| Tacrolimus Generic | 34 | 44 | 19 | $13K |
| Triamcinolone Acetonide Generic | 29 | 34 | 21 | $627 |
| Fluocinonide Generic | 27 | 27 | 12 | $443 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 25 | 28 | Under 11 | $114K |
| Metronidazole Generic | 23 | 24 | 14 | $462 |
| Hydrocortisone Generic | 22 | 29 | 18 | $449 |
| Mupirocin Generic | 18 | 18 | 18 | $209 |
| Methotrexate Methotrexate Sodium | 18 | 45 | Under 11 | $260 |
| Vectical Calcitriol | 16 | 20 | Under 11 | $11K |
| Prednisone Generic | 15 | 23 | Under 11 | $183 |
| Ketoconazole Generic | 15 | 15 | Under 11 | $218 |
| Imiquimod Generic | 13 | 17 | Under 11 | $298 |
Brand drugs: 130 claims; generic drugs: 478 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Mary L Bui were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.